Sotera Health (SHC) executive compensation, 2026 proxy

Michael B. Petras, Jr., Chairman and CEO, was paid $10.7M in 2025, up 3% from $10.4M the year before. The CEO-to-median-employee pay ratio was 129:1, on median employee pay of $82,784.

Filed
April 8, 2026
Annual meeting
May 21, 2026
Pay year
2025
Named executives
4
CEO total pay
$10.7M+3% vs prior year
CEO to median employee
129:1median $82,784
CEO pay in equity
75%$8M in awards
Prior say-on-pay support
99%of votes cast
CEO Target Bonus
$1,413,373Target AIP opportunity for 2025
Stockholders Say-On-Pay Approval
99%Support at 2025 Annual Meeting
Revenue Growth
5.7%Consolidated revenue growth to $1.164 billion
Adjusted EBITDA Growth
8.2%Increased to $594 million

How Jr. was paid

$10.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Stock awards75%Non-equity incentive14%All other compensation0%

Named executive officers

ExecutiveTotal
Michael B. Petras, Jr.Chairman and CEO$10,656,063
Jonathan LyonsSVP, CFO$3,086,383
Michael P. RutzPresident of Sterigenics$2,180,029
Alexander DimitriefFormer SVP and General Counsel$2,459,612

What changed and why

  • $10.7MChief executive officer total compensation increased to $10,656,063 in fiscal 2025 from $10,392,468 in fiscal 2024.
  • $1.164BRevenue grew by 5.7% to $1.164 billion, marking the 20th consecutive year of annual revenue growth.
  • $594MAdjusted EBITDA increased 8.2% to $594 million with margins expanding 118 basis points.
  • 99%Stockholders approved the prior say-on-pay proposal with over 99% support.
  • The company revised its long-term incentive program to introduce performance share units and eliminate stock options.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.